Pfizer-BioNTech says COVID-19 vaccine 80% effective in children under 5

Published May 23, 2022 2:05pm ET



The COVID-19 vaccine-maker Pfizer-BioNTech said Monday that its three-dose vaccine was about 80% effective in preventing symptomatic infection in children under 5, meaning shots for the youngest population could come within weeks.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.